Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 616850, 11 pages
http://dx.doi.org/10.1155/2014/616850
Research Article

The Role of Hypoxia-Inducible Factor-1α, Glucose Transporter-1, (GLUT-1) and Carbon Anhydrase IX in Endometrial Cancer Patients

1Department of Obstetrics and Gynecology, The Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University of Torun, Ulica Ujejskiego 75, 85-168 Bydgoszcz, Poland
2Department of Clinical Pathology, The Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University of Torun, 87-100 Torun, Poland
3Department of Gastroenterology, Angiology and Internal Diseases, The Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University of Torun, 87-100 Torun, Poland

Received 27 October 2013; Accepted 9 February 2014; Published 12 March 2014

Academic Editor: Jelena Urosevic

Copyright © 2014 Pawel Sadlecki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, J. Xu, and E. Ward, “Cancer statistics, 2010,” CA Cancer Journal for Clinicians, vol. 60, no. 5, pp. 277–300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Amant, P. Moerman, P. Neven, D. Timmerman, E. van Limbergen, and I. Vergote, “Endometrial cancer,” The Lancet, vol. 366, no. 9484, pp. 491–505, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. J. N. Bakkum-Gamez, J. Gonzalez-Bosquet, N. N. Laack, A. Mariani, and S. C. Dowdy, “Current issues in the management of endometrial cancer,” Mayo Clinic Proceedings, vol. 83, no. 1, pp. 97–112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. S. Shay and M. Celeste Simon, “Hypoxia-inducible factors: crosstalk between inflammation and metabolism,” Seminars in Cell and Developmental Biology, vol. 23, pp. 389–394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Liu, S.-M. Shen, X.-Y. Zhao, and G.-Q. Chen, “Targeted genes and interacting proteins of hypoxia inducible factor-1,” International Journal of Biochemistry and Molecular Biology, vol. 3, pp. 165–178, 2012. View at Google Scholar
  6. H. Zhong, A. M. de Marzo, E. Laughner et al., “Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases,” Cancer Research, vol. 59, no. 22, pp. 5830–5835, 1999. View at Google Scholar · View at Scopus
  7. E. A. O'Toole, R. van Koningsveld, M. Chen, and D. T. Woodley, “Hypoxia induces epidermal keratinocyte matrix metalloproteinase-9 secretion via the protein kinase C pathway,” Journal of Cellular Physiology, vol. 214, no. 1, pp. 47–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Ishikawa, K.-I. Nakashiro, S. K. Klosek et al., “Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma,” Oncology Reports, vol. 21, no. 3, pp. 707–712, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Li, X. Qiu, S. Zhang, Q. Zhang, and E. Wang, “Hypoxia induced CCR7 expression via HIF-1α and HIF-2α correlates with migration and invasion in lung cancer cells,” Cancer Biology and Therapy, vol. 8, no. 4, pp. 322–330, 2009. View at Google Scholar · View at Scopus
  10. Q. Sun, H. Zhou, N. O. Binmadi, and J. R. Basile, “Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity,” Journal of Biological Chemistry, vol. 284, no. 46, pp. 32066–32074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Z.-B. Han, H. Ren, H. Zhao et al., “Hypoxia-inducible factor (HIF)-1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF),” Carcinogenesis, vol. 29, no. 10, pp. 1853–1861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. B. D. Kelly, S. F. Hackett, K. Hirota et al., “Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1,” Circulation Research, vol. 93, no. 11, pp. 1074–1081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. O. Warburg, “On the origin of cancer cells,” Science, vol. 123, no. 3191, pp. 309–314, 1956. View at Google Scholar · View at Scopus
  14. M. Hayashi, M. Sakata, T. Takeda et al., “Induction of glucose transporter 1 expression through hypoxia-inducible factor 1α under hypoxic conditions in trophoblast-derived cells,” Journal of Endocrinology, vol. 183, no. 1, pp. 145–154, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. J. W. Calvert, J. Cahill, M. Yamaguchi-Okada, and J. H. Zhang, “Oxygen treatment after experimental hypoxia-ischemia in neonatal rats alters the expression of HIF-1α and its downstream target genes,” Journal of Applied Physiology, vol. 101, no. 3, pp. 853–865, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Liu, Y.-M. Li, R.-F. Tian et al., “The expression and significance of HIF-1α and GLUT-3 in glioma,” Brain Research, vol. 1304, pp. 149–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Chen, N. Pore, A. Behrooz, F. Ismail-Beigi, and A. Maity, “Regulation of glut1 mRNA by hypoxia-inducible factor-1: interaction between H-ras and hypoxia,” Journal of Biological Chemistry, vol. 276, no. 12, pp. 9519–9525, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Potter and A. L. Harris, “Hypoxia inducible carbonic anhydrase IX, marker of tumor hypoxia, survival pathway and therapy target,” Cell Cycle, vol. 3, no. 2, pp. 164–167, 2004. View at Google Scholar · View at Scopus
  19. A. Thiry, J.-M. Dogné, B. Masereel, and C. T. Supuran, “Targeting tumor-associated carbonic anhydrase IX in cancer therapy,” Trends in Pharmacological Sciences, vol. 27, no. 11, pp. 566–573, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Remmele and H. E. Stegner, “Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue,” Pathologe, vol. 8, no. 3, pp. 138–140, 1987. View at Google Scholar · View at Scopus
  21. V. Dousias, T. Vrekoussis, I. Navrozoglou et al., “Hypoxia-induced factor-1a in endometrial carcinoma: a mini-review of current evidence,” Histology and Histopathology, vol. 27, pp. 1247–1253, 2012. View at Google Scholar
  22. L. M. S. Seeber, R. P. Zweemer, R. H. M. Verheijen, and P. J. van Diest, “Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer management,” Obstetrics and Gynecology International, vol. 2010, Article ID 580971, 8 pages, 2010. View at Publisher · View at Google Scholar
  23. M. Nakamura, J. M. Bodily, M. Beglin, S. Kyo, M. Inoue, and L. A. Laimins, “Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses,” Virology, vol. 387, no. 2, pp. 442–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. H. O. D. Critchley, J. Osei, T. A. Henderson et al., “Hypoxia-inducible factor-1 expression in human endometrium and its regulation by prostaglandin E-series prostanoid receptor 2 (EP2),” Endocrinology, vol. 147, no. 2, pp. 744–753, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. A. Maybin, N. Hirani, P. Brown, H. N. Jabbour, and H. O. D. Critchley, “The regulation of vascular endothelial growth factor by hypoxia and prostaglandin F2α during human endometrial repair,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 8, pp. 2475–2483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Orimo, Y. Tomioka, Y. Shimizu et al., “Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression,” Clinical Cancer Research, vol. 7, no. 10, pp. 3097–3105, 2001. View at Google Scholar · View at Scopus
  27. R. D. Catalano, M. R. Wilson, S. C. Boddy, A. T. M. McKinlay, K. J. Sales, and H. N. Jabbour, “Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth,” PLoS ONE, vol. 6, no. 5, Article ID e19209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Horrée, P. J. van Diest, P. van der Groep, D. M. D. S. Sie-Go, and A. P. M. Heintz, “Hypoxia and angiogenesis in endometrioid endometrial carcinogenesis,” Cellular Oncology, vol. 29, no. 3, pp. 219–227, 2007. View at Google Scholar · View at Scopus
  29. E. Konac, H. I. Onen, J. Metindir, E. Alp, A. A. Biri, and A. Ekmekci, “An investigation of relationships between hypoxia-inducible factor-1α gene polymorphisms and ovarian, cervical and endometrial cancers,” Cancer Detection and Prevention, vol. 31, no. 2, pp. 102–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. M. P. Myers, I. Pass, I. H. Batty et al., “The lipid phosphatase activity of PTEN is critical for its tumor supressor function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 23, pp. 13513–13518, 1998. View at Publisher · View at Google Scholar · View at Scopus
  31. P. J. Wysocki, “MTOR in renal cell cancer: Modulator of tumor biology and therapeutic target,” Expert Review of Molecular Diagnostics, vol. 9, no. 3, pp. 231–241, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Fujimoto, E. Sato, S. M. Alam et al., “Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers,” Oncology, vol. 71, no. 1-2, pp. 95–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Pansare, A. R. Munkarah, V. Schimp et al., “Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas,” Modern Pathology, vol. 20, no. 1, pp. 35–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. L. M. S. Seeber, N. Horrée, P. van der Groep, E. van der Wall, R. H. M. Verheijen, and P. J. van Diest, “Necrosis related HIF-1α expression predicts prognosis in patients with endometrioid endometrial carcinoma,” BMC Cancer, vol. 10, article 307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Sivridis, A. Giatromanolaki, K. C. Gatter, A. L. Harris, and M. I. Koukourakis, “Association of hypoxia-inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma,” Cancer, vol. 95, no. 5, pp. 1055–1063, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Giatromanolaki, M. I. Koukourakis, K. C. Gatter, A. L. Harris, and E. Sivridis, “BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1α pathway and prognosis,” Journal of Clinical Pathology, vol. 61, no. 2, pp. 217–220, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Acs, X. Xu, C. Chu, P. Acs, and A. Verma, “Prognostic significance of erythropoietin expression in human endometrial carcinoma,” Cancer, vol. 100, no. 11, pp. 2376–2386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. A. M. Oza, L. Elit, M.-S. Tsao et al., “Phase II study of temsirolimus in women with recurrent or metastatic endometrial cancer: a trial of the NCIC Clinical Trials Group,” Journal of Clinical Oncology, vol. 29, no. 24, pp. 3278–3285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Xiong, Y. Y. Xiong, and Y. F. Zhou, “Expression and significance of β-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma,” European Journal of Gynaecological Oncology, vol. 31, no. 2, pp. 160–164, 2010. View at Google Scholar · View at Scopus
  40. Y. Noguchi, A. Saito, Y. Miyagi et al., “Suppression of facilitative glucose transporter 1 mRNA can suppress tumor growth,” Cancer Letters, vol. 154, no. 2, pp. 175–182, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Knapp, A. Chabowski, D. Harasiuk, and J. Górski, “Reversed glucose and fatty acids transporter expression in human endometrial cancer,” Hormone and Metabolic Research, vol. 44, pp. 436–441, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Hynninen, S. Parkkila, H. Huhtala et al., “Carbonic anhydrase isozymes II, IX, and XII in uterine tumors,” APMIS, vol. 120, no. 2, pp. 117–129, 2012. View at Publisher · View at Google Scholar · View at Scopus